High expression levels of CCL22 and CCL17 are positively correlated with CD4+ T cell infiltration and a favorable prognosis with ICI treatment in patients with head and neck carcinoma (Zhou et al., 2022). The gene discussed is CCL22; the disease is head and neck carcinoma.